Nuveen’s Aratana Therapeutics, Inc. PETX Stock Holding History

Nuveen’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-329,494	Closed	-$1.7M	–	3284
2019 Q2	$1.7M	Buy	+329,494	New	+$1.48M	﹤0.01%	2509

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Nuveen's PETX Position: Q3 2019 in Review

Nuveen sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 329,494 shares — an estimated $1.7M sold.

Nuveen first reported a position in PETX in Q2 2019 and held it in 1 quarter. The position peaked at $1.7M in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Nuveen reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Nuveen sold 329,494 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $1.7M.
Nuveen first reported a position in Aratana Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
Nuveen's Aratana Therapeutics, Inc. position peaked at $1.7M in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Nuveen's 13F filing for Q3 2019, filed 14 Nov 2019.